Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Johnson_&_Johnson
|
| gptkbp:acquisitionYear |
2017
|
| gptkbp:CEO |
gptkb:Jean-Paul_Clozel
|
| gptkbp:country |
gptkb:Switzerland
|
| gptkbp:foundedBy |
gptkb:Jean-Paul_Clozel
gptkb:Martine_Clozel |
| gptkbp:foundedIn |
1997
|
| gptkbp:headquartersLocation |
Allschwil, Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Actelion Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Opsumit
gptkb:Tracleer gptkb:Uptravi |
| gptkbp:numberOfEmployees |
~2500
|
| gptkbp:parentCompany |
gptkb:Johnson_&_Johnson
|
| gptkbp:specializesIn |
pulmonary arterial hypertension
|
| gptkbp:spinOff |
Idorsia
|
| gptkbp:stockExchange |
gptkb:SIX_Swiss_Exchange
|
| gptkbp:stockSymbol |
gptkb:ATLN
|
| gptkbp:website |
https://www.actelion.com/
|
| gptkbp:bfsParent |
gptkb:Orbit_Image_Analysis
|
| gptkbp:bfsLayer |
6
|